Anke Loregger

735 total citations
17 papers, 466 citations indexed

About

Anke Loregger is a scholar working on Surgery, Molecular Biology and Biochemistry. According to data from OpenAlex, Anke Loregger has authored 17 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 10 papers in Molecular Biology and 6 papers in Biochemistry. Recurrent topics in Anke Loregger's work include Cholesterol and Lipid Metabolism (12 papers), Lipid metabolism and biosynthesis (6 papers) and Cancer, Lipids, and Metabolism (4 papers). Anke Loregger is often cited by papers focused on Cholesterol and Lipid Metabolism (12 papers), Lipid metabolism and biosynthesis (6 papers) and Cancer, Lipids, and Metabolism (4 papers). Anke Loregger collaborates with scholars based in Netherlands, Austria and Australia. Anke Loregger's co-authors include Noam Zelcer, Emma C. L. Cook, Andrew J. Brown, Laura J. Sharpe, Lisa Phan, Saskia Scheij, Ika Kristiana, Julian Stevenson, Marlene van den Berg and Michel van Weeghel and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Anke Loregger

17 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anke Loregger Netherlands	12	261	174	132	110	80	17	466
Pia Stillemark-Billton Sweden	9	263 1.0×	116 0.7×	100 0.8×	129 1.2×	153 1.9×	11	570
F Benoist Canada	8	236 0.9×	168 1.0×	99 0.8×	97 0.9×	105 1.3×	12	446
Marie‐Elisabeth Samson‐Bouma France	7	182 0.7×	188 1.1×	63 0.5×	68 0.6×	82 1.0×	10	431
Elisa N.D. Palladino United States	10	284 1.1×	120 0.7×	134 1.0×	49 0.4×	71 0.9×	13	536
Jerry Angdisen United States	12	300 1.1×	187 1.1×	73 0.6×	42 0.4×	58 0.7×	23	583
Xiao-Yi Lu China	5	167 0.6×	117 0.7×	80 0.6×	41 0.4×	20 0.3×	7	352
Hyunjoo Kwon United States	9	279 1.1×	76 0.4×	181 1.4×	72 0.7×	17 0.2×	20	451
Gerard Vassiliou Canada	10	164 0.6×	127 0.7×	58 0.4×	46 0.4×	38 0.5×	12	363
Madlen Matz‐Soja Germany	15	300 1.1×	94 0.5×	75 0.6×	43 0.4×	30 0.4×	42	592
Ni Zeng United States	10	246 0.9×	108 0.6×	78 0.6×	22 0.2×	34 0.4×	15	405

Countries citing papers authored by Anke Loregger

Since Specialization

Citations

This map shows the geographic impact of Anke Loregger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Loregger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Loregger more than expected).

Fields of papers citing papers by Anke Loregger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anke Loregger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Loregger. The network helps show where Anke Loregger may publish in the future.

Co-authorship network of co-authors of Anke Loregger

This figure shows the co-authorship network connecting the top 25 collaborators of Anke Loregger. A scholar is included among the top collaborators of Anke Loregger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anke Loregger. Anke Loregger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Ottenhoff, Roelof, et al.. (2024). SPRING is a Dedicated Licensing Factor for SREBP-Specific Activation by S1P. Molecular and Cellular Biology. 44(4). 123–137. 5 indexed citations

Ottenhoff, Roelof, Monika Svecla, Vinay Sachdev, et al.. (2023). Hepatic SREBP signaling requires SPRING to govern systemic lipid metabolism in mice and humans. Nature Communications. 14(1). 5181–5181. 23 indexed citations

Stoel, Miesje M. van der, Marlene van den Berg, Martina Moeton, et al.. (2020). The MARCH6-SQLE Axis Controls Endothelial Cholesterol Homeostasis and Angiogenic Sprouting. Cell Reports. 32(5). 107944–107944. 19 indexed citations

Loregger, Anke, Matthijs Raaben, Joppe Nieuwenhuis, et al.. (2020). Haploid genetic screens identify SPRING/C12ORF49 as a determinant of SREBP signaling and cholesterol metabolism. Nature Communications. 11(1). 1128–1128. 42 indexed citations

Oteng, Antwi‐Boasiako, Anke Loregger, Michel van Weeghel, Noam Zelcer, & Sander Kersten. (2019). Industrial Trans Fatty Acids Stimulate SREBP2‐Mediated Cholesterogenesis and Promote Non‐Alcoholic Fatty Liver Disease. Molecular Nutrition & Food Research. 63(19). e1900385–e1900385. 36 indexed citations

Loregger, Anke, et al.. (2019). FBXW7 regulates endothelial barrier function by suppression of the cholesterol synthesis pathway and prenylation of RhoB. Molecular Biology of the Cell. 30(5). 607–621. 13 indexed citations

Cook, Emma C. L., et al.. (2018). Differential use of E2 ubiquitin conjugating enzymes for regulated degradation of the rate-limiting enzymes HMGCR and SQLE in cholesterol biosynthesis. Atherosclerosis. 281. 137–142. 33 indexed citations

Loregger, Anke, Jessica K. Nelson, & Noam Zelcer. (2017). Assaying Low-Density-Lipoprotein (LDL) Uptake into Cells. Methods in molecular biology. 1583. 53–63. 8 indexed citations

Cook, Emma C. L., Jessica K. Nelson, Vincenzo Sorrentino, et al.. (2017). Identification of the ER-resident E3 ubiquitin ligase RNF145 as a novel LXR-regulated gene. PLoS ONE. 12(2). e0172721–e0172721. 23 indexed citations

10.

Loregger, Anke, Matthijs Raaben, Saskia Scheij, et al.. (2017). Haploid Mammalian Genetic Screen Identifies UBXD8 as a Key Determinant of HMGCR Degradation and Cholesterol Biosynthesis. Arteriosclerosis Thrombosis and Vascular Biology. 37(11). 2064–2074. 27 indexed citations

11.

Loregger, Anke, Emma C. L. Cook, Jessica K. Nelson, et al.. (2016). A MARCH6 and IDOL E3 ubiquitin ligase circuit uncouples cholesterol synthesis from lipoprotein uptake in hepatocytes. Atherosclerosis. 252. e250–e250. 4 indexed citations

12.

Nelson, Jessica K., Emma C. L. Cook, Anke Loregger, et al.. (2015). Deubiquitylase Inhibition Reveals Liver X Receptor-independent Transcriptional Regulation of the E3 Ubiquitin Ligase IDOL and Lipoprotein Uptake. Journal of Biological Chemistry. 291(9). 4813–4825. 16 indexed citations

13.

Loregger, Anke, Emma C. L. Cook, Martina Moeton, et al.. (2015). A MARCH6 and IDOL E3 Ubiquitin Ligase Circuit Uncouples Cholesterol Synthesis from Lipoprotein Uptake in Hepatocytes. Molecular and Cellular Biology. 36(2). 285–294. 37 indexed citations

14.

Lu, Xifeng, Marcel E. Meima, Jessica K. Nelson, et al.. (2015). Identification of the (Pro)renin Receptor as a Novel Regulator of Low-Density Lipoprotein Metabolism. Circulation Research. 118(2). 222–229. 34 indexed citations

15.

Loregger, Anke, Anne John, Boris Bleijlevens, et al.. (2014). Impaired trafficking of the very low density lipoprotein receptor caused by missense mutations associated with dysequilibrium syndrome. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1843(12). 2871–2877. 10 indexed citations

16.

Zelcer, Noam, Laura J. Sharpe, Anke Loregger, et al.. (2014). The E3 Ubiquitin Ligase MARCH6 Degrades Squalene Monooxygenase and Affects 3-Hydroxy-3-Methyl-Glutaryl Coenzyme A Reductase and the Cholesterol Synthesis Pathway. Molecular and Cellular Biology. 34(7). 1262–1270. 135 indexed citations

17.

Loregger, Anke, et al.. (2009). Characterization of a novel Modulator of the Wnt signaling pathway. Zeitschrift für Gastroenterologie. 47(10). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact